Home Top Movers ThermoGenesis Holdings, Inc. (THMO) Stock Continues Trending Up With Easing of Pandemic...

ThermoGenesis Holdings, Inc. (THMO) Stock Continues Trending Up With Easing of Pandemic Restrictions

ThermoGenesis Holdings, Inc. (THMO) stock prices were up by 5.83% as of the market closing on May 24th, 2021, bringing the price per share up to USD$2.54 at the end of the trading day.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

PXP-LAVARE Progress

The company announced early in February of 2021 that it had finished the process of developing its innovative PXP-LAVARE System. Concurrently, THMO submitted a Letter to File with an updated device listing to the U.S Food and Drug Administration (FDA). The proprietary system is GMP compliant and facilitates the rapid, automated, and reliable washing of cells. The System is designed as an optional cell reformulation accessory, intended to be used alongside THMO’s PXP-1000 System, which is a 510(k) Class II medical device that serves to isolate different cellular components from blood.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Net Revenue Decline

THMO reported USD$1.5 million in net revenues for the quarter ended March 31st, 2021, a significant decrease from the USD$3.2 million reported as of March 31st, 2020. The 53% dip was largely attributable to AXP disposable sales, which saw a USD$1.9 million decline with roughly 900 fewer cases being sold in the first quarter of the fiscal year 2021 as compared to the prior year.

Pandemic Challenges

A major driver of the decrease in net revenues is the ongoing and significant adverse effect of the global pandemic on the company’s sale reports. As the global economy hurtles towards universal immunizations, the relaxing of restrictions and government-mandated regulations has resulted in THMO getting ready for the second quarter of fiscal 2021 that will see a modicum of normalcy being returned to the industry.

Post-pandemic Recovery

March of the fiscal year 2021 saw an increase in inquiries for orders, leading the company to believe that revenue will recover in the second quarter of 2021. THMO forecasts that the return of revenue to levels seen before the onset of the pandemic will happen by the end of 2021. The silver lining in the most recent financial reports is that off the decrease in revenue being partially offset by a USD$0.3 million increase in BioArchive sales as a result of increased service revenue.

Solid Liquidity Position

THMO reported having cash and cash equivalents amounting to a total of USD$10 million as of March 31st, 2021, up from the USD$7.2 million reported as of December 31st, 2020. Working capital reported as of March 31st, 2021 was USD$6.4 million, while working capital reports from December 31st, 2020 pegged it at USD$9.2 million.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for THMO

Armed with a solid liquidity position, THMO is positioning itself to capitalize on the post-pandemic return to economic normalcy. Current and potential investors are hopeful that the company will continue to leverage the resources at its disposal to facilitate significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Here’s why Soligenix, Inc. (SNGX) stock is Popping High today

Soligenix, Inc. (SNGX) stock gained Pediatric Investigation Plan (PIP) waiver for HyBryte™ (SGX301 or hypericin) by European Medicines Agency (EMA) after which the SNGX...

Clover Health Investments Corp. (CLOV) stock rises during pre-market. Let’s find out why?

Clover Health Investments Corp. (NASDAQ: CLOV) stock declined by 23.61% at last close while the CLOV stock price gains by 5.73% in the pre-market...

GameStop Inc. (GME) stock plunged during after-hour session. Here’s the update

GameStop Inc. (NASDAQ: GME) stock gained by 0.85% at the last close while the GME stock price declines by 5.21% in the after-hours session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam